India's drug regulator has granted restricted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in......
The COVID-19 pandemic took a deadlier and more devastating turn in 2021 soon after a glimmer of hope was provided by the launch of vaccines at the beginning of the year, etching nightmarish......
'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.' IMAGE: COVID-19 vaccination in Jaipur,......
Bharat Biotech's Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said.......
Prime Minister Narendra Modi announced on Saturday that vaccination against COVID-19 for children between 15-18 years will start from January 3, while "precaution dose" for healthcare and frontline......
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......
The government hopes that the PLI schemes would provide 200,000-300,000 direct employment over five years, according to sources in the know. In a move that has lifted the industry sentiment in the......
Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation. Even as the......
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......